Developer docs
API playgroundTry for free, no card

Search company profiles

Cancer Centre London

Full company profile

uuid002rdk9

Namestring
Cancer Centre London
Legal namestring
Icon Cancer Centre UK
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Cancer Centre London, operating as Icon Cancer Centre UK, is a private oncology day hospital located at 49 Parkside, Wimbledon, London (SW19 5NB). Founded in 2003, the centre provides fee-for-service cancer treatment to private patients in London and surrounding areas, with payment made directly or through private health insurance. The facility is a UK subsidiary of Icon Group, the Asia-Pacific cancer care operator with centres across Australia, New Zealand, Singapore, Malaysia, Indonesia, and the UK, and operates in formal partnership with Nuffield Health to access its specialist network and patient referral pathways.

The centre's clinical offering centres on advanced radiation therapy, including stereotactic radiotherapy, HyperArc, adaptive radiotherapy, Deep Inspiration Breath Hold (DIBH), hydrogel spacer placement, external beam radiotherapy, and low-dose radiotherapy for benign conditions. This is complemented by systemic therapies — chemotherapy, immunotherapy, targeted therapies, hormone therapy, and theranostics — plus bone marrow collection and supportive services (counselling, pain management, palliative care, physiotherapy, dietetics). Patients are treated across breast, prostate, bowel, lung, and haematological cancers, blood disorders, and selected benign conditions, with a primary segment being breast cancer patients.

Go-to-market is hybrid: direct-to-consumer via website enquiry and phone, plus sales-led consultant and GP referrals through the Nuffield Health partnership. Pricing is quote-based per treatment course and not publicly disclosed. The centre is currently undertaking refurbishment works, indicating capital reinvestment in the existing facility. No revenue, headcount, or funding data are disclosed in the available sources.

Short descriptiontext

Private cancer day hospital in Wimbledon, London, part of Icon Group, delivering advanced radiotherapy, chemotherapy, immunotherapy, and targeted therapies to self-pay and insured patients across London and the South East.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, private oncology care, radiotherapy services, chemotherapy treatment, precision cancer therapy
Industry3 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Radiation Oncology
CodeHLAKAFACPrimaryNo
3Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
NAICS code1 code
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code1 code
  • Services-Hospitals8060
Product category
Oncology Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Private Healthcare Services
TypeOne Time License
Description

Fee-for-service revenue model providing cancer treatment services including radiotherapy, chemotherapy, immunotherapy, and other treatments to private patients. As a private cancer centre, patients pay for treatment directly or through private health insurance.

iconcancercentre.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Quote-based pricing for individual treatment courses
ModelOtherBilling cadenceMulti-year contract
Notes

Treatment costs are determined based on individual patient needs, cancer type, and treatment plan. No standard pricing tiers are publicly listed.

iconcancercentre.co.uk
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Cancer Centre London (operating as Icon Cancer Centre UK) is a private cancer treatment hospital in Wimbledon providing comprehensive oncology services to patients across London and surrounding areas. The centre delivers advanced radiotherapy (including stereotactic, HyperArc, adaptive, DIBH, hydrogel, EBRT, and low-dose techniques), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. Services are organised around specific cancer types including breast, prostate, bowel, lung, blood cancers, blood disorders, and selected benign conditions.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Icon Cancer Centre London operates as a private healthcare facility offering integrated cancer treatment services. The centre provides a comprehensive portfolio of treatment modalities including radiotherapy (with advanced techniques such as HyperArc, Adaptive radiotherapy, and Stereotactic radiotherapy), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. The centre specializes in treating various cancer types including breast, prostate, bowel, lung, and blood cancers, as well as blood disorders and benign conditions. Patient support services including a cancer library, support services for families and carers, and care coordination complement the clinical treatments. The centre operates in partnership with Nuffield Health to deliver coordinated cancer care.

Product and service15 records
1Radiotherapy
CategoryTreatment service
Description

Cancer treatment using targeted radiation, delivered through advanced techniques including stereotactic radiotherapy, HyperArc, adaptive radiotherapy, Deep Inspiration Breath Hold (DIBH), hydrogel spacers, external beam radiotherapy (EBRT), and low-dose radiotherapy (LDRT). Provided to patients seeking precision radiation treatment at the Wimbledon centre.

2Chemotherapy
CategoryTreatment service
Description

Systemic cancer treatment using cytotoxic drugs to destroy cancer cells, offered with supporting services for starting treatment and managing side effects.

3Immunotherapy
CategoryTreatment service
Description

Cancer treatment that harnesses the body's immune system to fight cancer cells, including checkpoint inhibitors and other immune-modulating therapies.

4Hormone Therapy
CategoryTreatment service
Description

Cancer treatment using hormones to slow or stop the growth of certain cancers.

5Targeted Therapies
CategoryTreatment service
Description

Precision cancer treatments that target specific genes, proteins, or pathways unique to a patient's cancer to block tumour growth and spread.

6Theranostics
CategoryTreatment service
Description

Combined diagnostic and therapeutic approach using radiopharmaceuticals to both identify and treat cancer cells simultaneously.

7Bone Marrow Collection
CategoryTreatment service
Description

Procedure for collecting bone marrow stem cells for transplantation or therapeutic purposes.

8Icon Cancer Centre London (Wimbledon facility)
CategoryCore facility service
Description

Private cancer treatment centre located at 49 Parkside, Wimbledon, London SW19 5NB, providing comprehensive cancer care including radiotherapy, chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection for patients across London and surrounding areas.

9Breast Cancer Treatment
CategoryCondition-specific treatment
Description

Specialised diagnosis and treatment services for breast cancer patients, including radiotherapy, chemotherapy, hormone therapy, and targeted therapies with techniques such as Deep Inspiration Breath Hold to minimise cardiac exposure.

10Prostate Cancer Treatment
CategoryCondition-specific treatment
Description

Specialised diagnosis and treatment services for prostate cancer patients, including radiotherapy with hydrogel spacer technique to reduce rectal side effects, hormone therapy, and targeted approaches.

11Bowel Cancer Treatment
CategoryCondition-specific treatment
Description

Specialised diagnosis and treatment services for bowel (colorectal) cancer patients, including radiotherapy and systemic therapies with coordinated multidisciplinary care.

12Lung Cancer Treatment
CategoryCondition-specific treatment
Description

Specialised diagnosis and treatment services for lung cancer patients, including radiotherapy, chemotherapy, immunotherapy, and targeted therapies.

13Blood Cancers Treatment
CategoryCondition-specific treatment
Description

Treatment services for haematological malignancies including leukaemia, lymphoma, and myeloma, with systemic therapies and bone marrow collection.

14Blood Disorders Treatment
CategoryCondition-specific treatment
Description

Treatment services for non-malignant blood disorders including anaemia, iron deficiency, haemochromatosis, and myelodysplasia.

15Benign Conditions Treatment
CategoryCondition-specific treatment
Description

Low-dose radiotherapy treatment for benign conditions including Dupuytren's disease, Ledderhose disease, osteoarthritis, and plantar fasciitis.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Icon Cancer Centre has a partnership with Nuffield Health to deliver seamless, high-quality cancer care. Patients benefit from access to world-class treatments, care from leading consultants, and coordinated support from hundreds of specialists. The partnership enables integrated care pathways combining Nuffield Health's facilities and specialist network with Icon's cancer expertise.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Strategic partner of Cancer Centre London. Operates a UK network of private hospitals and fitness/wellness facilities and refers cancer patients to Icon's London centre — comparable as a private-pay UK healthcare ecosystem participant and partner-channel.

TypeBroad incumbent
Description

UK-wide private hospital group offering oncology services including chemotherapy across multiple London and regional sites. Comparable on the private-pay oncology delivery model, though less specialist depth than a dedicated cancer centre.

TypeBroad incumbent
Description

Large independent private hospital in central London offering oncology among many other specialties. Comparable as a London private-pay provider with cancer services, but broader scope and less specialist depth in advanced radiotherapy.

TypeBroad incumbent
Description

Flagship HCA private hospital in London with a significant cancer services programme. Overlaps with Cancer Centre London in private oncology delivery but sits within a much larger multi-specialty private hospital group.

5The Royal Marsden Private Care
TypeDirect peer
Description

The UK's most renowned specialist cancer hospital, offering private patient services in London with comprehensive radiotherapy, chemotherapy and systemic therapy — directly comparable to Cancer Centre London in service mix, technology depth and London private-pay patient base.

TypeBroad incumbent
Description

London private hospital offering cancer diagnostics and treatment services including radiotherapy. Comparable as a private London provider, though broader multi-specialty positioning rather than a dedicated oncology centre.

TypeDirect peer
Description

Specialist private cancer care provider with multiple UK centres offering advanced radiotherapy (including stereotactic), chemotherapy and theranostics — directly comparable technology stack and private-pay model with a multi-site UK footprint that Icon Cancer Centre London lacks.

TypeBroad incumbent
Description

International private hospital operator with UK sites offering cancer treatment including chemotherapy and radiotherapy. Comparable as a private-pay provider but operates a broad multi-specialty portfolio rather than a focused cancer offering.

9Leaders in Oncology Care (LOC)
TypeDirect peer
Description

London-based private oncology provider (part of HCA Healthcare UK) delivering chemotherapy, immunotherapy, radiotherapy and supportive care — competes head-on with Cancer Centre London for self-pay and insured cancer patients in central London.

TypeOthers
Description

Major UK private health insurer and provider with cancer treatment pathways. Comparable as a counterparty in the UK private cancer care ecosystem — both a potential payer (reimbursing Cancer Centre London treatments) and an indirect competitor via its own health services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cancer Centre London

Oncology Servicescancercentrelondon.co.uk

Private cancer day hospital in Wimbledon, London, part of Icon Group, delivering advanced radiotherapy, chemotherapy, immunotherapy, and targeted therapies to self-pay and insured patients across London and the South East.

What Cancer Centre London does

Cancer Centre London, operating as Icon Cancer Centre UK, is a private oncology day hospital located at 49 Parkside, Wimbledon, London (SW19 5NB). Founded in 2003, the centre provides fee-for-service cancer treatment to private patients in London and surrounding areas, with payment made directly or through private health insurance. The facility is a UK subsidiary of Icon Group, the Asia-Pacific cancer care operator with centres across Australia, New Zealand, Singapore, Malaysia, Indonesia, and the UK, and operates in formal partnership with Nuffield Health to access its specialist network and patient referral pathways.

The centre's clinical offering centres on advanced radiation therapy, including stereotactic radiotherapy, HyperArc, adaptive radiotherapy, Deep Inspiration Breath Hold (DIBH), hydrogel spacer placement, external beam radiotherapy, and low-dose radiotherapy for benign conditions. This is complemented by systemic therapies — chemotherapy, immunotherapy, targeted therapies, hormone therapy, and theranostics — plus bone marrow collection and supportive services (counselling, pain management, palliative care, physiotherapy, dietetics). Patients are treated across breast, prostate, bowel, lung, and haematological cancers, blood disorders, and selected benign conditions, with a primary segment being breast cancer patients.

Go-to-market is hybrid: direct-to-consumer via website enquiry and phone, plus sales-led consultant and GP referrals through the Nuffield Health partnership. Pricing is quote-based per treatment course and not publicly disclosed. The centre is currently undertaking refurbishment works, indicating capital reinvestment in the existing facility. No revenue, headcount, or funding data are disclosed in the available sources.

Cancer Centre London firmographics

Firmographics
Name
Cancer Centre London
Legal name
Icon Cancer Centre UK
Website
https://cancercentrelondon.co.uk
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
1–10 employees
Short description
Private cancer day hospital in Wimbledon, London, part of Icon Group, delivering advanced radiotherapy, chemotherapy, immunotherapy, and targeted therapies to self-pay and insured patients across London and the South East.
Ownership category
akta.pro rank

Cancer Centre London industry classification

Industry
Product category
Oncology Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-Hospitals (8060)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Radiation Oncology (HLAKAFAC), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

  • Cancer treatment services
  • Private oncology care
  • Radiotherapy services
  • Chemotherapy treatment
  • Precision cancer therapy

Where Cancer Centre London is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Cancer Centre London business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Private Healthcare Services: Fee-for-service revenue model providing cancer treatment services including radiotherapy, chemotherapy, immunotherapy, and other treatments to private patients. As a private cancer centre, patients pay for treatment directly or through private health insurance.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for individual treatment courses

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Cancer Centre London product offering

Product offering

Core offering

Cancer Centre London (operating as Icon Cancer Centre UK) is a private cancer treatment hospital in Wimbledon providing comprehensive oncology services to patients across London and surrounding areas. The centre delivers advanced radiotherapy (including stereotactic, HyperArc, adaptive, DIBH, hydrogel, EBRT, and low-dose techniques), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. Services are organised around specific cancer types including breast, prostate, bowel, lung, blood cancers, blood disorders, and selected benign conditions.

Product overview

Icon Cancer Centre London operates as a private healthcare facility offering integrated cancer treatment services. The centre provides a comprehensive portfolio of treatment modalities including radiotherapy (with advanced techniques such as HyperArc, Adaptive radiotherapy, and Stereotactic radiotherapy), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. The centre specializes in treating various cancer types including breast, prostate, bowel, lung, and blood cancers, as well as blood disorders and benign conditions. Patient support services including a cancer library, support services for families and carers, and care coordination complement the clinical treatments. The centre operates in partnership with Nuffield Health to deliver coordinated cancer care.

Differentiator

Problem solved

Functional benefit

Products and services

  • Radiotherapy Cancer treatment using targeted radiation, delivered through advanced techniques including stereotactic radiotherapy, HyperArc, adaptive radiotherapy, Deep Inspiration Breath Hold (DIBH), hydrogel spacers, external beam radiotherapy (EBRT), and low-dose radiotherapy (LDRT). Provided to patients seeking precision radiation treatment at the Wimbledon centre.
  • Chemotherapy Systemic cancer treatment using cytotoxic drugs to destroy cancer cells, offered with supporting services for starting treatment and managing side effects.
  • Immunotherapy Cancer treatment that harnesses the body's immune system to fight cancer cells, including checkpoint inhibitors and other immune-modulating therapies.
  • Hormone Therapy Cancer treatment using hormones to slow or stop the growth of certain cancers.
  • Targeted Therapies Precision cancer treatments that target specific genes, proteins, or pathways unique to a patient's cancer to block tumour growth and spread.
  • Theranostics Combined diagnostic and therapeutic approach using radiopharmaceuticals to both identify and treat cancer cells simultaneously.
  • Bone Marrow Collection Procedure for collecting bone marrow stem cells for transplantation or therapeutic purposes.
  • Icon Cancer Centre London (Wimbledon facility) Private cancer treatment centre located at 49 Parkside, Wimbledon, London SW19 5NB, providing comprehensive cancer care including radiotherapy, chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection for patients across London and surrounding areas.
  • Breast Cancer Treatment Specialised diagnosis and treatment services for breast cancer patients, including radiotherapy, chemotherapy, hormone therapy, and targeted therapies with techniques such as Deep Inspiration Breath Hold to minimise cardiac exposure.
  • Prostate Cancer Treatment Specialised diagnosis and treatment services for prostate cancer patients, including radiotherapy with hydrogel spacer technique to reduce rectal side effects, hormone therapy, and targeted approaches.
  • Bowel Cancer Treatment Specialised diagnosis and treatment services for bowel (colorectal) cancer patients, including radiotherapy and systemic therapies with coordinated multidisciplinary care.
  • Lung Cancer Treatment Specialised diagnosis and treatment services for lung cancer patients, including radiotherapy, chemotherapy, immunotherapy, and targeted therapies.
  • Blood Cancers Treatment Treatment services for haematological malignancies including leukaemia, lymphoma, and myeloma, with systemic therapies and bone marrow collection.
  • Blood Disorders Treatment Treatment services for non-malignant blood disorders including anaemia, iron deficiency, haemochromatosis, and myelodysplasia.
  • Benign Conditions Treatment Low-dose radiotherapy treatment for benign conditions including Dupuytren's disease, Ledderhose disease, osteoarthritis, and plantar fasciitis.

Companies that use Cancer Centre London

Customer profile

Segments6 records

Ideal customer profiles2 records

Cancer Centre London technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature12 records

Cancer Centre London partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Nuffield HealthcoreStrategic or Co-development PartnerIcon Cancer Centre has a partnership with Nuffield Health to deliver seamless, high-quality cancer care. Patients benefit from access to world-class treatments, care from leading consultants, and coordinated support from hundreds of specialists. The partnership enables integrated care pathways combining Nuffield Health's facilities and specialist network with Icon's cancer expertise.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Cancer Centre London competitors and assessment

Company assessment

Others

  • Nuffield Health: Strategic partner of Cancer Centre London. Operates a UK network of private hospitals and fitness/wellness facilities and refers cancer patients to Icon's London centre — comparable as a private-pay UK healthcare ecosystem participant and partner-channel.
  • Bupa Health Services: Major UK private health insurer and provider with cancer treatment pathways. Comparable as a counterparty in the UK private cancer care ecosystem — both a potential payer (reimbursing Cancer Centre London treatments) and an indirect competitor via its own health services.

Broad incumbents

  • Spire Healthcare: UK-wide private hospital group offering oncology services including chemotherapy across multiple London and regional sites. Comparable on the private-pay oncology delivery model, though less specialist depth than a dedicated cancer centre.
  • The London Clinic: Large independent private hospital in central London offering oncology among many other specialties. Comparable as a London private-pay provider with cancer services, but broader scope and less specialist depth in advanced radiotherapy.
  • London Bridge Hospital (HCA Healthcare UK): Flagship HCA private hospital in London with a significant cancer services programme. Overlaps with Cancer Centre London in private oncology delivery but sits within a much larger multi-specialty private hospital group.
  • Cromwell Hospital: London private hospital offering cancer diagnostics and treatment services including radiotherapy. Comparable as a private London provider, though broader multi-specialty positioning rather than a dedicated oncology centre.
  • Ramsay Health Care UK: International private hospital operator with UK sites offering cancer treatment including chemotherapy and radiotherapy. Comparable as a private-pay provider but operates a broad multi-specialty portfolio rather than a focused cancer offering.

Direct peers

  • The Royal Marsden Private Care: The UK's most renowned specialist cancer hospital, offering private patient services in London with comprehensive radiotherapy, chemotherapy and systemic therapy — directly comparable to Cancer Centre London in service mix, technology depth and London private-pay patient base.
  • GenesisCare UK: Specialist private cancer care provider with multiple UK centres offering advanced radiotherapy (including stereotactic), chemotherapy and theranostics — directly comparable technology stack and private-pay model with a multi-site UK footprint that Icon Cancer Centre London lacks.
  • Leaders in Oncology Care (LOC): London-based private oncology provider (part of HCA Healthcare UK) delivering chemotherapy, immunotherapy, radiotherapy and supportive care — competes head-on with Cancer Centre London for self-pay and insured cancer patients in central London.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Cancer Centre London social profiles

Digital presence

Cancer Centre London financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cancer Centre London leadership team

Management profile

Number of profiles

Cancer Centre London funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cancer Centre London M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Centre London

What does Cancer Centre London do?

Cancer Centre London (operating as Icon Cancer Centre UK) is a private cancer treatment hospital in Wimbledon providing comprehensive oncology services to patients across London and surrounding areas. The centre delivers advanced radiotherapy (including stereotactic, HyperArc, adaptive, DIBH, hydrogel, EBRT, and low-dose techniques), chemotherapy, immunotherapy, hormone therapy, targeted therapies, theranostics, and bone marrow collection. Services are organised around specific cancer types including breast, prostate, bowel, lung, blood cancers, blood disorders, and selected benign conditions.

Is Cancer Centre London a public or private company?

Cancer Centre London is a private company. It is classified as corporate owned and is currently operating.

When was Cancer Centre London founded?

Cancer Centre London was founded in 2003. It employs 1 to 10 people.

Where is Cancer Centre London based?

Cancer Centre London is headquartered in London, United Kingdom, in the Europe region.

How does Cancer Centre London make money?

One revenue line is on record: private Healthcare Services.

Who are Cancer Centre London's main competitors?

Others on record are Nuffield Health and Bupa Health Services. Broad incumbents are Spire Healthcare, The London Clinic, London Bridge Hospital (HCA Healthcare UK), Cromwell Hospital and Ramsay Health Care UK. Direct peers are The Royal Marsden Private Care, GenesisCare UK and Leaders in Oncology Care (LOC).

Does Cancer Centre London have an API?

No public API is recorded for Cancer Centre London.

What industry is Cancer Centre London in?

Cancer Centre London's product category is Oncology Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales